We are proud to announce the selection of Dr. Reshma Ramracheya for an oral presentation at the prestigious Third European Association for the Study of Diabetes Incretin Study Group Meeting. Our Head of Pharmaceutical Operations will be discussing what is “known, new, controversial” in the incretin field so as to identify key questions that need to be addressed in clinical and fundamental science and propose key clinical trials.

Latest News
  • 24 December 2020 CIDP wishes you a Merry Christmas & a Happy New Year
  • 14 November 2020 WORLD DIABETES DAY - 14th November
  • 29 October 2020 CIDP keeps the Quality bar high!
Archives

Time Zone

Choose a centre